Abnormal functional connectivity density in Parkinson's disease

Behavioural Brain Research

Volumn 280, Issue , 2015, Pages 113-118

  Zhang, Jiuquan ^a   Bi, Wenwei ^b   Zhang, Yuling ^b   Zhu, Maohu ^c   Zhang, Yanling ^a   Feng, Hua ^a   Wang, Jian ^a   Zhang, Yuanchao ^b   Jiang, Tianzi ^b,d  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ELECTRONIC SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c JIANGXI NORMAL UNIVERSITY   (China)

^d INSTITUTE OF AUTOMATION   (China)

Author keywords

Functional connectivity; Functional connectivity density; Long range FCD; Parkinson's disease; Short range FCD

Indexed keywords

ADULT; ARTICLE; BRAIN FUNCTION; BRAIN MAPPING; BRAIN REGION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONNECTOME; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; MIDDLE FRONTAL GYRUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSTERIOR CINGULATE; PRECUNEUS; RESTING STATE NETWORK; SUPERIOR FRONTAL GYRUS; VISUAL HALLUCINATION; VOXEL BASED MORPHOMETRY; BRAIN; NERVE TRACT; PATHOPHYSIOLOGY; REST; SIGNAL PROCESSING;

BRAIN; BRAIN MAPPING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURAL PATHWAYS; PARKINSON DISEASE; REST; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 84919912953     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.12.007     Document Type: Article

References (50)

1. Tolosa E., Wenning G., Poewe W. The diagnosis of Parkinson's disease. Lancet Neurol 2006, 5:75-86.
2. Borghammer P., Chakravarty M., Jonsdottir K.Y., Sato N., Matsuda H., Ito K., et al. Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages. Brain Struct Funct 2010, 214:303-317.
3. Eberling J.L., Richardson B.C., Reed B.R., Wolfe N., Jagust W.J. Cortical glucose metabolism in Parkinson's disease without dementia. Neurobiol Aging 1994, 15:329-335.
4. Fernandez-Seara M.A., Mengual E., Vidorreta M., Aznarez-Sanado M., Loayza F.R., Villagra F., et al. Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI. NeuroImage 2012, 59:2743-2750.
5. Biundo R., Formento-Dojot P., Facchini S., Vallelunga A., Ghezzo L., Foscolo L., et al. Brain volume changes in Parkinson's disease and their relationship with cognitive and behavioural abnormalities. J Neurol Sci 2011, 310:64-69.
6. Pereira J.B., Ibarretxe-Bilbao N., Marti M.J., Compta Y., Junque C., Bargallo N., et al. Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness. Hum Brain Mapp 2012, 33:2521-2534.
7. Jubault T., Gagnon J.F., Karama S., Ptito A., Lafontaine A.L., Evans A.C., et al. Patterns of cortical thickness and surface area in early Parkinson's disease. NeuroImage 2011, 55:462-467.
8. Tinaz S., Courtney M.G., Stern C.E. Focal cortical and subcortical atrophy in early Parkinson's disease. Mov Disord 2011, 26:436-441.
9. Lyoo C.H., Ryu Y.H., Lee M.S. Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia. Mov Disord 2010, 25:496-499.
10. Zhang Y., Zhang J., Xu J., Wu X., Zhang Y., Feng H., et al. Cortical gyrification reductions and subcortical atrophy in Parkinson's disease. Mov Disord 2014, 29:122-126.
11. Apostolova L.G., Beyer M., Green A.E., Hwang K.S., Morra J.H., Chou Y.Y., et al. Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia. Mov Disord 2010, 25:687-695.
12. Hacker C.D., Perlmutter J.S., Criswell S.R., Ances B.M., Snyder A.Z. Resting state functional connectivity of the striatum in Parkinson's disease. Brain 2012, 135:3699-3711.
13. Helmich R.C., Derikx L.C., Bakker M., Scheeringa R., Bloem B.R., Toni I. Spatial remapping of cortico-striatal connectivity in Parkinson's disease. Cereb Cortex 2010, 20:1175-1186.
14. Luo C., Song W., Chen Q., Zheng Z., Chen K., Cao B., et al. Reduced functional connectivity in early-stage drug-naive Parkinson's disease: a resting-state fMRI study. Neurobiol Aging 2014, 35:431-441.
15. Wu T., Long X., Wang L., Hallett M., Zang Y., Li K., et al. Functional connectivity of cortical motor areas in the resting state in Parkinson's disease. Hum Brain Mapp 2011, 32:1443-1457.
16. Liu H., Edmiston E.K., Fan G., Xu K., Zhao B., Shang X., et al. Altered resting-state functional connectivity of the dentate nucleus in Parkinson's disease. Psychiatry Res 2013, 211:64-71.
17. Tomasi D., Volkow N.D. Functional connectivity density mapping. Proc Natl Acad Sci U S A 2010, 107:9885-9890.
18. Tomasi D., Volkow N.D. Aging and functional brain networks. Mol Psychiatry 2012, 17(471):549-558.
19. Tomasi D., Volkow N.D. Abnormal functional connectivity in children with attention-deficit/hyperactivity disorder. Biol Psychiatry 2012, 71:443-450.
20. Wang T., Li Q., Guo M., Peng Y., Li Q., Qin W., et al. Abnormal functional connectivity density in children with anisometropic amblyopia at resting-state. Brain Res 2014, 1563:41-51.
21. Qin W., Xuan Y., Liu Y., Jiang T., Yu C. Functional connectivity density in congenitally and late blind subjects. Cereb Cortex 2014.
22. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9:97-113.
23. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992, 55:181-184.
24. Fahn S., Elton R. Members of the UPDRS Development Committee: Unified Parkinson's Disease Rating Scale. Recent developments in Parkinson's disease, New York 1987, 153-163. S. Fahn, C.D. Marsden, D.B. Calne, M. Goldstein (Eds.).
25. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
26. Tomlinson C.L., Stowe R., Patel S., Rick C., Gray R., Clarke C.E. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010, 25:2649-2653.
27. Foerster B.U., Tomasi D., Caparelli E.C. Magnetic field shift due to mechanical vibration in functional magnetic resonance imaging. Magn Reson Med 2005, 54:1261-1267.
28. Cordes D., Haughton V.M., Arfanakis K., Carew J.D., Turski P.A., Moritz C.H., et al. Frequencies contributing to functional connectivity in the cerebral cortex in resting-state data. Am J Neuroradiol 2001, 22:1326-1333.
29. Tomasi D., Volkow N.D. Functional connectivity hubs in the human brain. NeuroImage 2011, 57:908-917.
30. Oishi N., Udaka F., Kameyama M., Sawamoto N., Hashikawa K., Fukuyama H. Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations. Neurology 2005, 65:1708-1715.
31. Ramirez-Ruiz B., Marti M.J., Tolosa E., Gimenez M., Bargallo N., Valldeoriola F., et al. Cerebral atrophy in Parkinson's disease patients with visual hallucinations. Eur J Neurol 2007, 14:750-756.
32. Lee E.Y., Sen S., Eslinger P.J., Wagner D., Shaffer M.L., Kong L., et al. Early cortical gray matter loss and cognitive correlates in non-demented Parkinson's patients. Parkinsonism Relat Disord 2013, 19:1088-1093.
33. Diederich N.J., Fenelon G., Stebbins G., Goetz C.G. Hallucinations in Parkinson disease. Nat Rev Neurol 2009, 5:331-342.
34. Melzer T.R., Watts R., MacAskill M.R., Pearson J.F., Rueger S., Pitcher T.L., et al. Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease. Brain 2011, 134:845-855.
35. Polito C., Berti V., Ramat S., Vanzi E., De Cristofaro M.T., Pellicano G., et al. Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease. Neurobiol Aging 2012, 33(206):e29-e39.
36. Jokinen P., Karrasch M., Bruck A., Johansson J., Bergman J., Rinne J.O. Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction. J Neurol Sci 2013, 329:23-28.
37. Gottlich M., Munte T.F., Heldmann M., Kasten M., Hagenah J., Kramer U.M. Altered resting state brain networks in Parkinson's disease. PLOS ONE 2013, 8:e77336.
38. Yang H., Zhou X.J., Zhang M.M., Zheng X.N., Zhao Y.L., Wang J. Changes in spontaneous brain activity in early Parkinson's disease. Neurosci Lett 2013, 549:24-28.
39. Long D., Wang J., Xuan M., Gu Q., Xu X., Kong D., et al. Automatic classification of early Parkinson's disease with multi-modal MR imaging. PLOS ONE 2012, 7:e47714.
40. Appel-Cresswell S., de la Fuente-Fernandez R., Galley S., McKeown M.J. Imaging of compensatory mechanisms in Parkinson's disease. Curr Opin Neurol 2010, 23:407-412.
41. van Eimeren T., Monchi O., Ballanger B., Strafella A.P. Dysfunction of the default mode network in Parkinson disease: a functional magnetic resonance imaging study. Arch Neurol 2009, 66:877-883.
42. Buckner R.L. Human functional connectivity: new tools, unresolved questions. Proc Natl Acad Sci U S A 2010, 107:10769-10770.
43. Fox M.D., Raichle M.E. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci 2007, 8:700-711.
44. van den Heuvel M.P., Hulshoff Pol H.E. Exploring the brain network: a review on resting-state fMRI functional connectivity. Eur Neuropsychopharmacol 2010, 20:519-534.
45. Ziegler E., Rouillard M., Andre E., Coolen T., Stender J., Balteau E., et al. Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease. NeuroImage 2014, 99:498-508.
46. Zhan W., Kang G.A., Glass G.A., Zhang Y., Shirley C., Millin R., et al. Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging. Mov Disord 2012, 27:90-97.
47. Gattellaro G., Minati L., Grisoli M., Mariani C., Carella F., Osio M., et al. White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. Am J Neuroradiol 2009, 30:1222-1226.
48. Rae C.L., Correia M.M., Altena E., Hughes L.E., Barker R.A., Rowe J.B. White matter pathology in Parkinson's disease: the effect of imaging protocol differences and relevance to executive function. NeuroImage 2012, 62:1675-1684.
49. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
50. Braak H., Ghebremedhin E., Rub U., Bratzke H., Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004, 318:121-134.